Healthcare M&A Transactions Under Heightened State and Federal Scrutiny: New Reporting Requirements
Recording of a 90-minute CLE video webinar with Q&A
This CLE webinar will guide healthcare counsel on the new reporting requirements for parties involved in healthcare M&A deals. The panel will examine the recent state legislative activity related to scrutiny of healthcare M&A deals and will discuss how the new laws are changing the playing field. The panel will address the considerations those involved in healthcare deals need to keep in mind and will offer best practices for navigating the new requirements.
- State activity and new reporting requirements
- New York
- Federal activity
- Best practices for navigating the new requirements
The panel will review these and other key issues:
- What transactions trigger the new reporting requirements?
- What factors are considered by the various state authorities when evaluating implicated healthcare deals?
- What best practices should counsel employ for navigating the new requirements?
Ari J. Markenson
Mr. Markenson practices at the intersection of healthcare, law, and business. He advises healthcare industry clients,... | Read More
Mr. Markenson practices at the intersection of healthcare, law, and business. He advises healthcare industry clients, including investors, lenders, providers, and suppliers, on a broad range of regulatory and corporate matters, and has significant experience conducting due diligence in complex healthcare industry acquisitions and financial transactions. He regularly represents private equity firms and lenders in such transactions and evaluates and advises on compliance and regulatory issues with regard to sellers and potential borrowers from banks and financing sources. He also advises various healthcare entities on regulatory matters, including conditions for participation, fraud and abuse, and survey, certification, licensure, and enforcement issues, Medicare and Medicaid conditions for participation, obtaining a certificate of need approval, and state licensure.Close
Ropes & Gray
Mr. Saran regularly advises healthcare companies and private equity investors on mergers and acquisitions and public... | Read More
Mr. Saran regularly advises healthcare companies and private equity investors on mergers and acquisitions and public offerings in the healthcare and life science industries, including hospitals and healthcare systems, physician and dental practices, management/dental service organizations and digital health companies. He also has experience in assisting provider platforms with their growth strategy including add-on acquisitions, complex service arrangements and joint ventures. Mr. Saran’s regulatory practice helps clients navigate matters related to the corporate practice of medicine, fraud and abuse laws, HIPAA, the CARES Act/COVID-19 laws and healthcare licensure.Close